{"id":20165,"date":"2026-02-23T10:06:55","date_gmt":"2026-02-23T13:06:55","guid":{"rendered":"https:\/\/acrisure.com.br\/insights\/?p=20165"},"modified":"2026-02-24T12:20:37","modified_gmt":"2026-02-24T15:20:37","slug":"ans-amplia-cobertura-obrigatoria","status":"publish","type":"post","link":"https:\/\/acrisure.com.br\/insights\/ans-amplia-cobertura-obrigatoria\/","title":{"rendered":"ANS amplia cobertura obrigat\u00f3ria de tratamentos na sa\u00fade suplementar"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Post&#8221; _builder_version=&#8221;4.19.4&#8243; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row admin_label=&#8221;Post&#8221; _builder_version=&#8221;4.27.3&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; width=&#8221;100%&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text admin_label=&#8221;Conte\u00fado&#8221; _builder_version=&#8221;4.27.5&#8243; _module_preset=&#8221;default&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||||false|false&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span data-contrast=\"auto\">A\u00a0<\/span><a href=\"https:\/\/www.gov.br\/ans\/pt-br\"><span data-contrast=\"none\">Ag\u00eancia Nacional de Sa\u00fade Suplementar (ANS) <\/span><\/a><span data-contrast=\"auto\">aprovou a incorpora\u00e7\u00e3o e atualiza\u00e7\u00e3o de Diretrizes de Utiliza\u00e7\u00e3o (DUTs) no Rol de Procedimentos e Eventos em Sa\u00fade, ampliando a cobertura obrigat\u00f3ria de medicamentos para\u00a0<\/span><b><span data-contrast=\"auto\">doen\u00e7as oncol\u00f3gicas, \u00f3sseas, inflamat\u00f3rias e hematol\u00f3gicas.<\/span><\/b><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335559738&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">As novas coberturas entram em vigor entre\u00a0<\/span><b><span data-contrast=\"auto\">janeiro e maio de 2026<\/span><\/b><span data-contrast=\"auto\">\u00a0e seguem a Lei 14.307\/2022, que determina que tecnologias recomendadas pela\u00a0Conitec\u00a0para o SUS sejam incorporadas ao Rol da sa\u00fade suplementar.\u00a0<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335559738&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n<h2 aria-level=\"2\"><span data-contrast=\"none\">Novas coberturas\u00a0em\u00a0oncologia<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;201341983&quot;:0,&quot;335551550&quot;:1,&quot;335551620&quot;:1,&quot;335559685&quot;:0,&quot;335559737&quot;:0,&quot;335559738&quot;:160,&quot;335559739&quot;:80,&quot;335559740&quot;:276}\">\u00a0<\/span><\/h2>\n<p><span data-contrast=\"auto\">A atualiza\u00e7\u00e3o inclui terapias direcionadas a diferentes tipos de c\u00e2ncer, com foco em tratamentos mais personalizados.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335559738&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n<h4 aria-level=\"4\"><i><span data-contrast=\"none\">C\u00e2ncer de mama precoce<\/span><\/i><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;201341983&quot;:0,&quot;335559738&quot;:80,&quot;335559739&quot;:40,&quot;335559740&quot;:276}\">\u00a0<\/span><\/h4>\n<p><span data-contrast=\"auto\">O\u00a0<\/span><b><span data-contrast=\"auto\">abemaciclibe<\/span><\/b><span data-contrast=\"auto\">\u00a0passa a ter cobertura obrigat\u00f3ria como tratamento adjuvante para adultos com c\u00e2ncer de mama inicial de alto risco de recorr\u00eancia, receptor hormonal positivo (RH+), HER2 negativo e linfonodo positivo.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335559738&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n<h4 aria-level=\"4\"><i><span data-contrast=\"none\">Mielofibrose<\/span><\/i><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;201341983&quot;:0,&quot;335559738&quot;:80,&quot;335559739&quot;:40,&quot;335559740&quot;:276}\">\u00a0<\/span><\/h4>\n<p><span data-contrast=\"auto\">O\u00a0<\/span><b><span data-contrast=\"auto\">momelotinibe<\/span><\/b><span data-contrast=\"auto\">\u00a0foi incorporado para tratamento de mielofibrose prim\u00e1ria, p\u00f3s-policitemia\u00a0vera ou p\u00f3s-trombocitemia essencial em adultos com anemia e risco intermedi\u00e1rio ou alto. O medicamento tamb\u00e9m passa a integrar as terapias antineopl\u00e1sicas orais com cobertura obrigat\u00f3ria.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<h3 aria-level=\"2\"><span data-contrast=\"none\">Novo tratamento para osteoporose grave<\/span><span data-ccp-props=\"{&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:160,&quot;335559739&quot;:80}\">\u00a0<\/span><\/h3>\n<p><span data-contrast=\"auto\">O\u00a0<\/span><b><span data-contrast=\"auto\">romosozumabe<\/span><\/b><span data-contrast=\"auto\">\u00a0passa a ser coberto para mulheres na p\u00f3s-menopausa com osteoporose grave que apresentem falha terap\u00eautica anterior, caracterizada por fraturas durante o tratamento ou perda significativa de densidade mineral \u00f3ssea.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">A inclus\u00e3o amplia o acesso a terapias avan\u00e7adas voltadas \u00e0 preven\u00e7\u00e3o de fraturas e complica\u00e7\u00f5es associadas.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<h3>Leia tamb\u00e9m<\/h3>\n<ul>\n<li><a href=\"https:\/\/acrisure.com.br\/insights\/dados-ans-custos-saude-empresas\/\" target=\"_blank\" rel=\"noopener\">O que os dados da ANS revelam para os custos de sa\u00fade<\/a><\/li>\n<li><a href=\"https:\/\/acrisure.com.br\/insights\/inadimplencia-convenios-medicos\/\" target=\"_blank\" rel=\"noopener\">Inadimpl\u00eancia em Conv\u00eanios M\u00e9dicos: como falhas podem afetar<\/a><\/li>\n<\/ul>\n<h2 aria-level=\"2\"><span data-contrast=\"none\">Amplia\u00e7\u00e3o para doen\u00e7as imunol\u00f3gicas e hematol\u00f3gicas<\/span><span data-ccp-props=\"{&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:160,&quot;335559739&quot;:80}\">\u00a0<\/span><\/h2>\n<p><span data-contrast=\"auto\">A atualiza\u00e7\u00e3o tamb\u00e9m incorpora terapias relevantes para doen\u00e7as cr\u00f4nicas de alta complexidade.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335559738&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n<h4 aria-level=\"4\"><i><span data-contrast=\"none\">Dermatite at\u00f3pica moderada a grave<\/span><\/i><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;201341983&quot;:0,&quot;335559738&quot;:80,&quot;335559739&quot;:40,&quot;335559740&quot;:276}\">\u00a0<\/span><\/h4>\n<p><span data-contrast=\"auto\">O\u00a0<\/span><b><span data-contrast=\"auto\">metotrexato<\/span><\/b><span data-contrast=\"auto\">\u00a0injet\u00e1vel ambulatorial passa a ter cobertura para pacientes de qualquer idade conforme crit\u00e9rios cl\u00ednicos definidos.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335559738&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n<h4 aria-level=\"4\"><i><span data-contrast=\"none\">Hemofilia A grave<\/span><\/i><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;201341983&quot;:0,&quot;335559738&quot;:80,&quot;335559739&quot;:40,&quot;335559740&quot;:276}\">\u00a0<\/span><\/h4>\n<p><span data-contrast=\"auto\">O\u00a0<\/span><b><span data-contrast=\"auto\">emicizumabe<\/span><\/b><span data-contrast=\"auto\">\u00a0foi incorporado para profilaxia de crian\u00e7as at\u00e9 seis anos com hemofilia A grave sem inibidores do fator VIII.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335559738&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n<h3 aria-level=\"2\"><span data-contrast=\"none\">Novo medicamento para retocolite ulcerativa<\/span><span data-ccp-props=\"{&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:160,&quot;335559739&quot;:80}\">\u00a0<\/span><\/h3>\n<p><span data-contrast=\"auto\">O\u00a0<\/span><b><span data-contrast=\"auto\">risanquizumabe<\/span><\/b><span data-contrast=\"auto\">\u00a0passa a ter cobertura obrigat\u00f3ria para adultos com retocolite ulcerativa moderada a grave que n\u00e3o responderam adequadamente a terapias anteriores. A obrigatoriedade come\u00e7a em maio de 2026.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335559738&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Durante a avalia\u00e7\u00e3o, foi considerado o impacto or\u00e7ament\u00e1rio, com compromisso de negocia\u00e7\u00e3o de pre\u00e7os entre fabricante e setor.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<h2 aria-level=\"3\"><span data-contrast=\"none\">Por que a atualiza\u00e7\u00e3o do Rol \u00e9 relevante<\/span><span data-ccp-props=\"{&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:160,&quot;335559739&quot;:80}\">\u00a0<\/span><\/h2>\n<p><span data-contrast=\"auto\">A incorpora\u00e7\u00e3o de novas tecnologias representa um avan\u00e7o importante no acesso a tratamentos, mas tamb\u00e9m traz\u00a0<\/span><b><span data-contrast=\"auto\">impactos para o equil\u00edbrio financeiro<\/span><\/b><span data-contrast=\"auto\">\u00a0da sa\u00fade suplementar.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">A inclus\u00e3o de medicamentos de alto custo tende a:<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"9\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">Aumentar a complexidade assistencial<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"9\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span data-contrast=\"auto\">Elevar a press\u00e3o sobre custos m\u00e9dicos<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"9\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"3\" data-aria-level=\"1\"><span data-contrast=\"auto\">Exigir maior previsibilidade e gest\u00e3o de risco<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/li>\n<\/ul>\n<p><span data-contrast=\"auto\">Para empresas contratantes de planos de sa\u00fade, essas mudan\u00e7as refor\u00e7am a import\u00e2ncia da\u00a0<\/span><b><span data-contrast=\"auto\">gest\u00e3o ativa de <a href=\"https:\/\/acrisure.com.br\/insights\/category\/beneficios\/\">benef\u00edcios<\/a><\/span><\/b><span data-contrast=\"auto\">, da an\u00e1lise de dados assistenciais e da busca por estrat\u00e9gias que conciliem acesso, qualidade e sustentabilidade.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A digitaliza\u00e7\u00e3o e a automa\u00e7\u00e3o de tarefas n\u00e3o s\u00e3o tend\u00eancias futuras:\u00a0elas j\u00e1 transformam hoje a organiza\u00e7\u00e3o, performance e riscos no trabalho. O foco para l\u00edderes n\u00e3o \u00e9 a tecnologia isoladamente, mas\u00a0seus efeitos sobre pessoas, sa\u00fade e resultados do neg\u00f3cio.\u00a0<\/p>\n","protected":false},"author":1,"featured_media":20174,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[78],"tags":[95],"class_list":["post-20165","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ans","tag-legislacao"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ANS amplia cobertura obrigat\u00f3ria de tratamentos<\/title>\n<meta name=\"description\" content=\"A\u00a0ANS aprovou a atualiza\u00e7\u00e3o no Rol, ampliando a cobertura para\u00a0doen\u00e7as oncol\u00f3gicas, \u00f3sseas, inflamat\u00f3rias e hematol\u00f3gicas.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/acrisure.com.br\/insights\/ans-amplia-cobertura-obrigatoria\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ANS amplia cobertura obrigat\u00f3ria de tratamentos\" \/>\n<meta property=\"og:description\" content=\"A\u00a0ANS aprovou a atualiza\u00e7\u00e3o no Rol, ampliando a cobertura para\u00a0doen\u00e7as oncol\u00f3gicas, \u00f3sseas, inflamat\u00f3rias e hematol\u00f3gicas.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/acrisure.com.br\/insights\/ans-amplia-cobertura-obrigatoria\/\" \/>\n<meta property=\"og:site_name\" content=\"Insights \/ Acrisure\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/itsseg\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-23T13:06:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-24T15:20:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/acrisure.com.br\/insights\/wp-content\/uploads\/medicamentos-tratamento-doencas.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1620\" \/>\n\t<meta property=\"og:image:height\" content=\"650\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"publishouse\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"publishouse\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":[\"Article\",\"BlogPosting\"],\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ans-amplia-cobertura-obrigatoria\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ans-amplia-cobertura-obrigatoria\\\/\"},\"author\":{\"name\":\"publishouse\",\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/#\\\/schema\\\/person\\\/ae285068bde2d94bbb6b0692760fb361\"},\"headline\":\"ANS amplia cobertura obrigat\u00f3ria de tratamentos na sa\u00fade suplementar\",\"datePublished\":\"2026-02-23T13:06:55+00:00\",\"dateModified\":\"2026-02-24T15:20:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ans-amplia-cobertura-obrigatoria\\\/\"},\"wordCount\":621,\"image\":{\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ans-amplia-cobertura-obrigatoria\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/wp-content\\\/uploads\\\/medicamentos-tratamento-doencas.jpg\",\"keywords\":[\"Legisla\u00e7\u00e3o\"],\"articleSection\":[\"ANS\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ans-amplia-cobertura-obrigatoria\\\/\",\"url\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ans-amplia-cobertura-obrigatoria\\\/\",\"name\":\"ANS amplia cobertura obrigat\u00f3ria de tratamentos\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ans-amplia-cobertura-obrigatoria\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ans-amplia-cobertura-obrigatoria\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/wp-content\\\/uploads\\\/medicamentos-tratamento-doencas.jpg\",\"datePublished\":\"2026-02-23T13:06:55+00:00\",\"dateModified\":\"2026-02-24T15:20:37+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/#\\\/schema\\\/person\\\/ae285068bde2d94bbb6b0692760fb361\"},\"description\":\"A\u00a0ANS aprovou a atualiza\u00e7\u00e3o no Rol, ampliando a cobertura para\u00a0doen\u00e7as oncol\u00f3gicas, \u00f3sseas, inflamat\u00f3rias e hematol\u00f3gicas.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ans-amplia-cobertura-obrigatoria\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ans-amplia-cobertura-obrigatoria\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ans-amplia-cobertura-obrigatoria\\\/#primaryimage\",\"url\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/wp-content\\\/uploads\\\/medicamentos-tratamento-doencas.jpg\",\"contentUrl\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/wp-content\\\/uploads\\\/medicamentos-tratamento-doencas.jpg\",\"width\":1620,\"height\":650,\"caption\":\"Falling pills on a blue background. Antibiotics.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ans-amplia-cobertura-obrigatoria\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ANS amplia cobertura obrigat\u00f3ria de tratamentos na sa\u00fade suplementar\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/#website\",\"url\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/\",\"name\":\"Insights \\\/ Acrisure\",\"description\":\"Portal de Not\u00edcias e Conte\u00fado\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/#\\\/schema\\\/person\\\/ae285068bde2d94bbb6b0692760fb361\",\"name\":\"publishouse\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/28cbb1595e2bba31bae82123e62ffe5e807440c64f2e05ed85a7bd654289e026?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/28cbb1595e2bba31bae82123e62ffe5e807440c64f2e05ed85a7bd654289e026?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/28cbb1595e2bba31bae82123e62ffe5e807440c64f2e05ed85a7bd654289e026?s=96&d=mm&r=g\",\"caption\":\"publishouse\"},\"sameAs\":[\"https:\\\/\\\/acrisure.com.br\\\/insights\"],\"url\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/author\\\/publishouse\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ANS amplia cobertura obrigat\u00f3ria de tratamentos","description":"A\u00a0ANS aprovou a atualiza\u00e7\u00e3o no Rol, ampliando a cobertura para\u00a0doen\u00e7as oncol\u00f3gicas, \u00f3sseas, inflamat\u00f3rias e hematol\u00f3gicas.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/acrisure.com.br\/insights\/ans-amplia-cobertura-obrigatoria\/","og_locale":"pt_BR","og_type":"article","og_title":"ANS amplia cobertura obrigat\u00f3ria de tratamentos","og_description":"A\u00a0ANS aprovou a atualiza\u00e7\u00e3o no Rol, ampliando a cobertura para\u00a0doen\u00e7as oncol\u00f3gicas, \u00f3sseas, inflamat\u00f3rias e hematol\u00f3gicas.\u00a0","og_url":"https:\/\/acrisure.com.br\/insights\/ans-amplia-cobertura-obrigatoria\/","og_site_name":"Insights \/ Acrisure","article_publisher":"https:\/\/www.facebook.com\/itsseg\/","article_published_time":"2026-02-23T13:06:55+00:00","article_modified_time":"2026-02-24T15:20:37+00:00","og_image":[{"width":1620,"height":650,"url":"https:\/\/acrisure.com.br\/insights\/wp-content\/uploads\/medicamentos-tratamento-doencas.jpg","type":"image\/jpeg"}],"author":"publishouse","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"publishouse","Est. tempo de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":["Article","BlogPosting"],"@id":"https:\/\/acrisure.com.br\/insights\/ans-amplia-cobertura-obrigatoria\/#article","isPartOf":{"@id":"https:\/\/acrisure.com.br\/insights\/ans-amplia-cobertura-obrigatoria\/"},"author":{"name":"publishouse","@id":"https:\/\/acrisure.com.br\/insights\/#\/schema\/person\/ae285068bde2d94bbb6b0692760fb361"},"headline":"ANS amplia cobertura obrigat\u00f3ria de tratamentos na sa\u00fade suplementar","datePublished":"2026-02-23T13:06:55+00:00","dateModified":"2026-02-24T15:20:37+00:00","mainEntityOfPage":{"@id":"https:\/\/acrisure.com.br\/insights\/ans-amplia-cobertura-obrigatoria\/"},"wordCount":621,"image":{"@id":"https:\/\/acrisure.com.br\/insights\/ans-amplia-cobertura-obrigatoria\/#primaryimage"},"thumbnailUrl":"https:\/\/acrisure.com.br\/insights\/wp-content\/uploads\/medicamentos-tratamento-doencas.jpg","keywords":["Legisla\u00e7\u00e3o"],"articleSection":["ANS"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/acrisure.com.br\/insights\/ans-amplia-cobertura-obrigatoria\/","url":"https:\/\/acrisure.com.br\/insights\/ans-amplia-cobertura-obrigatoria\/","name":"ANS amplia cobertura obrigat\u00f3ria de tratamentos","isPartOf":{"@id":"https:\/\/acrisure.com.br\/insights\/#website"},"primaryImageOfPage":{"@id":"https:\/\/acrisure.com.br\/insights\/ans-amplia-cobertura-obrigatoria\/#primaryimage"},"image":{"@id":"https:\/\/acrisure.com.br\/insights\/ans-amplia-cobertura-obrigatoria\/#primaryimage"},"thumbnailUrl":"https:\/\/acrisure.com.br\/insights\/wp-content\/uploads\/medicamentos-tratamento-doencas.jpg","datePublished":"2026-02-23T13:06:55+00:00","dateModified":"2026-02-24T15:20:37+00:00","author":{"@id":"https:\/\/acrisure.com.br\/insights\/#\/schema\/person\/ae285068bde2d94bbb6b0692760fb361"},"description":"A\u00a0ANS aprovou a atualiza\u00e7\u00e3o no Rol, ampliando a cobertura para\u00a0doen\u00e7as oncol\u00f3gicas, \u00f3sseas, inflamat\u00f3rias e hematol\u00f3gicas.\u00a0","breadcrumb":{"@id":"https:\/\/acrisure.com.br\/insights\/ans-amplia-cobertura-obrigatoria\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/acrisure.com.br\/insights\/ans-amplia-cobertura-obrigatoria\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/acrisure.com.br\/insights\/ans-amplia-cobertura-obrigatoria\/#primaryimage","url":"https:\/\/acrisure.com.br\/insights\/wp-content\/uploads\/medicamentos-tratamento-doencas.jpg","contentUrl":"https:\/\/acrisure.com.br\/insights\/wp-content\/uploads\/medicamentos-tratamento-doencas.jpg","width":1620,"height":650,"caption":"Falling pills on a blue background. Antibiotics."},{"@type":"BreadcrumbList","@id":"https:\/\/acrisure.com.br\/insights\/ans-amplia-cobertura-obrigatoria\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/acrisure.com.br\/insights\/"},{"@type":"ListItem","position":2,"name":"ANS amplia cobertura obrigat\u00f3ria de tratamentos na sa\u00fade suplementar"}]},{"@type":"WebSite","@id":"https:\/\/acrisure.com.br\/insights\/#website","url":"https:\/\/acrisure.com.br\/insights\/","name":"Insights \/ Acrisure","description":"Portal de Not\u00edcias e Conte\u00fado","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/acrisure.com.br\/insights\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/acrisure.com.br\/insights\/#\/schema\/person\/ae285068bde2d94bbb6b0692760fb361","name":"publishouse","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/28cbb1595e2bba31bae82123e62ffe5e807440c64f2e05ed85a7bd654289e026?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/28cbb1595e2bba31bae82123e62ffe5e807440c64f2e05ed85a7bd654289e026?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/28cbb1595e2bba31bae82123e62ffe5e807440c64f2e05ed85a7bd654289e026?s=96&d=mm&r=g","caption":"publishouse"},"sameAs":["https:\/\/acrisure.com.br\/insights"],"url":"https:\/\/acrisure.com.br\/insights\/author\/publishouse\/"}]}},"_links":{"self":[{"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/posts\/20165","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/comments?post=20165"}],"version-history":[{"count":5,"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/posts\/20165\/revisions"}],"predecessor-version":[{"id":20189,"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/posts\/20165\/revisions\/20189"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/media\/20174"}],"wp:attachment":[{"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/media?parent=20165"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/categories?post=20165"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/tags?post=20165"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}